FDA Removes Top Spokesperson After Blood Plasma Blunder
Emily Miller was central in defending the FDA commissioner, Dr. Stephen Hahn, after he falsely said that blood plasma could lower the death rate from COVID-19 by more than a third.
by Joe Neel
Aug 28, 2020
3 minutes
Updated at 8:30 p.m. ET
The Food and Drug Administration has removed a top communications official at the agency in the wake of misleading claims the agency made about a treatment for COVID-19.
Emily Miller was central in defending the FDA commissioner, Dr. Stephen Hahn, this week after he falsely said that blood plasma could lower the death rate from COVID-19 by more than a third. Hahn later apologized on Twitter. He remains on the job.
A statement from the FDA late Friday said onlyby earlier Friday.
You’re reading a preview, subscribe to read more.
Start your free 30 days